Product
601
1 clinical trial
1 indication
Indication
Retinal Vein OcclusionClinical trial
A Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of 601 Versus Ranibizumab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)Status: Recruiting, Estimated PCD: 2025-12-01